Evaluation of second-line treatment options in non-small cell lung cancerSCAGLIOTTI, Giorgio V.Seminars in oncology. 2006, Vol 33, Num 1, issn 0093-7754, 52 p., SUP1Serial Issue

Second-line treatment options in advanced non-small cell lung cancer : Current statusCULLEN, Michael.Seminars in oncology. 2006, Vol 33, Num 1, issn 0093-7754, S3-S8, SUP1Article

Management of bone metastases in cancer : A reviewSELVAGGI, Giovanni; SCAGLIOTTI, Giorgio V.Critical reviews in oncology/hematology. 2005, Vol 56, Num 3, pp 365-378, issn 1040-8428, 14 p.Article

Optimizing therapy in previously treated non-small cell lung cancerMILLER, Vincent A.Seminars in oncology. 2006, Vol 33, Num 1, issn 0093-7754, S25-S31, SUP1Article

The emerging role of MET/HGF inhibitors in oncologySCAGLIOTTI, Giorgio V; NOVELLO, Silvia; VON PAWEL, Joachim et al.Cancer treatment reviews. 2013, Vol 39, Num 7, pp 793-801, issn 0305-7372, 9 p.Article

Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancerSCAGLIOTTI, Giorgio V.Seminars in oncology. 2005, Vol 32, Num 2, pp 5-8, issn 0093-7754, 4 p., SUP2Article

Use of novel second-line targeted therapies in non-small cell lung cancerMASSARELLI, Erminia; HERBST, Roy S.Seminars in oncology. 2006, Vol 33, Num 1, issn 0093-7754, S9-S16, SUP1Article

Efficacy of neoadjuvant strategies with gemcitabine and other chemotherapy in resectable non-small cell lung cancer: A combined modality approachSCAGLIOTTI, Giorgio V; NOVELLO, Silvia.Seminars in oncology. 2003, Vol 30, Num 4, pp 13-18, issn 0093-7754, 6 p., SUP10Article

Docetaxel in combined-modality treatment of inoperable locally or regionally advanced lung cancerSCAGLIOTTI, Giorgio V; DOUILLARD, J.-Y.Lung cancer. 2004, Vol 46, pp s13-s21, issn 0169-5002, SUP2Article

Second-line treatment options in non-small cell lung cancer : A comparison of cytotoxic agents and targeted therapiesDE MARINIS, Filippo; DE SANTIS, Stefano; DE PETRIS, Luigi et al.Seminars in oncology. 2006, Vol 33, Num 1, issn 0093-7754, S17-S24, SUP1Article

Geographic variation in the second-line treatment of non-small cell lung cancerEDELMAN, Martin J; SEKINE, Ikuo; TAMURA, Tomohide et al.Seminars in oncology. 2006, Vol 33, Num 1, issn 0093-7754, S39-S44, SUP1Article

Neuro-endocrine tumours of the lung. A review of relevant pathological and molecular dataRIGHI, Luisella; VOLANTE, Marco; RAPA, Ida et al.Virchows Archiv. 2007, Vol 451, issn 0945-6317, S51-S59, SUP1Article

Cathepsin K is selectively expressed in the stroma of lung adenocarcinoma but not in bronchioloalveolar carcinoma : A useful marker of invasive growthRAPA, Ida; VOLANTE, Marco; CAPPIA, Susanna et al.American journal of clinical pathology. 2006, Vol 125, Num 6, pp 847-854, issn 0002-9173, 8 p.Article

Time to Activate Lung Cancer Clinical Trials and Patient Enrollment: A Representative Comparison Study Between Two Academic Centers Across the AtlanticWANG-GILLAM, Andrea; WILLIAMS, Kristina; NOVELLO, Silvia et al.Journal of clinical oncology. 2010, Vol 28, Num 24, pp 3803-3807, issn 0732-183X, 5 p.Article

Basaloid adenocarcinoma. A new variant of pulmonary adenocarcinomaMARCI, Valerio; VOLANTE, Marco; CAPPIA, Susanna et al.Virchows Archiv. 2007, Vol 451, Num 3, pp 729-736, issn 0945-6317, 8 p.Article

Immunohistochemical Subtyping of Nonsmall Cell Lung Cancer Not Otherwise Specified in Fine-Needle Aspiration Cytology: A Retrospective Study of 103 Cases With Surgical CorrelationRIGHI, Luisella; GRAZIANO, Paolo; FORNARI, Alessandro et al.Cancer. 2011, Vol 117, Num 15, pp 3416-3423, issn 0008-543X, 8 p.Article

Prognostic Role of Osteopontin Expression in Malignant Pleural MesotheliomaCAPPIA, Susanna; RIGHI, Luisella; MIRABELLI, Dario et al.American journal of clinical pathology. 2008, Vol 130, Num 1, pp 58-64, issn 0002-9173, 7 p.Article

Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): A combined analysis of three phase 3 trialsTREAT, Joseph; SCAGLIOTTI, Giorgio V; GUANGBIN PENG et al.Lung cancer. 2012, Vol 76, Num 2, pp 222-227, issn 0169-5002, 6 p.Article

Thymidylate Synthase But Not Excision Repair Cross-Complementation Group 1 Tumor Expression Predicts Outcome in Patients With Malignant Pleural Mesothelioma Treated With Pemetrexed-Based ChemotherapyRIGHI, Luisella; PAPOTTI, Mauro G; CEPPI, Paolo et al.Journal of clinical oncology. 2010, Vol 28, Num 9, pp 1534-1539, issn 0732-183X, 6 p.Article

The biology of epidermal growth factor receptor in lung cancerSCAGLIOTTI, Giorgio V; SELVAGGI, Giovanni; NOVELLO, Silvia et al.Clinical cancer research. 2004, Vol 10, Num 12, pp 4227s-4232s, issn 1078-0432, 2Conference Paper

Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancerGIACHINO, Daniela F; GHIO, Paolo; REGAZZONI, Silvia et al.Clinical cancer research. 2007, Vol 13, Num 10, pp 2876-2881, issn 1078-0432, 6 p.Article

The emergence of a unique population in non-small cell lung cancer : Systemic or loco- regional relapse following postoperative adjuvant platinum-based chemotherapySOCINSKI, Mark A; STINCHCOMBE, Thomas E; HAYES, D. Neil et al.Seminars in oncology. 2006, Vol 33, Num 1, issn 0093-7754, S32-S38, SUP1Article

Future directions in the second-line treatment of non-small cell lung cancerROSELL, Rafael; CECERE, Fabiana; COGNETTI, Francesco et al.Seminars in oncology. 2006, Vol 33, Num 1, issn 0093-7754, S45-S51, SUP1Article

A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancerSCAGLIOTTI, Giorgio V; GERMONPRE, Paul; BIESMA, Bonne et al.Lung cancer. 2010, Vol 68, Num 3, pp 420-426, issn 0169-5002, 7 p.Article

Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the LungMONICA, Valentina; SCAGLIOTTI, Giorgio V; CEPPI, Paolo et al.Clinical cancer research (Print). 2009, Vol 15, Num 24, pp 7547-7552, issn 1078-0432, 6 p.Article